Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06240351 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Evaluate the Safety and Efficacy of Baricitinib in the Treatment of Frontal Fibrosing Alopecia (FFA)

StatusActive, Not Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Minor Primary completion pushed from Jul 31, 2026 to Oct 31, 2026 Completion pushed from Jul 31, 2027 to Sep 30, 2027v7 Show 1 more changeShow less
    • Completion pushed from Jul 31, 2027 to Sep 30, 2027
  2. Minor Trial status: Recruiting to Active, Not Recruiting Site details revisedv6 Show 1 more changeShow less
    • Site details revised
  3. Notable Primary completion date: Apr 30, 2025 to Jul 31, 2026 Completion date: Dec 31, 2025 to Jul 31, 2027v5 Show 1 more changeShow less
    • Completion date: Dec 31, 2025 to Jul 31, 2027
  4. Notable Trial status: Not Yet Recruiting to Recruiting Primary completion date: Dec 31, 2024 to Apr 30, 2025 · Completion date: Dec 31, 2024 to Dec 31, 2025 · Start date changed from estimate of Jun 1, 2024 to Apr 22, 2024 · 1 morev4 Show 4 more changesShow less
    • Primary completion date: Dec 31, 2024 to Apr 30, 2025
    • Completion date: Dec 31, 2024 to Dec 31, 2025
    • Start date changed from estimate of Jun 1, 2024 to Apr 22, 2024
    • Site details revised
  5. Notable Start date: Apr 1, 2024 to Jun 1, 2024v3
  6. Notable Start date: Feb 20, 2024 to Apr 1, 2024v2
  7. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to evaluate the safety and efficacy of Baricitinib in the treatment of frontal fibrosing alopecia (FFA).
Trial Details
NCT Number NCT06240351
Lead Sponsor University of Alabama at Birmingham
Collaborators: Eli Lilly and Company
Conditions Frontal Fibrosing Alopecia
Enrollment 15 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov